FDA Agrees to Review Naloxegol for Use in Opioid-Induced Constipation

The FDA has accepted a New Drug Application for naloxegol , an investigational peripherally acting mu-opioid receptor antagonist.

http://www.pharmscope.com/news/DailyDetail.cfm?chosen=68035